Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APRF and EMD for Healing After Third Molar Extraction
NCT06190015Phase 4Active, not recruiting
- Sponsor
- University of Belgrade
- Start
- May 2022
- Primary completion
- Jan 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of advanced platelet-rich fibrin, enamel matrix derivative in surgical wound, postoperative pain, sponsored by University of Belgrade. Started May 2022; status: active, not recruiting.
02
Drugs
advanced platelet-rich fibrinenamel matrix derivative
03
Conditions
surgical woundpostoperative pain
Beyond the preview
Go deeper on NCT06190015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06190015.